SM

Sarv Mitter Behl

Director Director DIN 00175986
DIN 00175986 First appointment Jul 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2004
Shareholding value Locked Premium profile

About Sarv Mitter Behl

Data last updated:

Sarv Mitter Behl has 22 years in corporate governance. Formerly with 1 company, such as Cytogen Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00175986
Primary Designation Director
First Appointment 22 Jul 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director22 Jul 20042003Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cytogen Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Sarv Mitter Behl

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarv Mitter Behl

Sarv Mitter Behl has 22 years in corporate governance. Formerly with 1 company, such as Cytogen Pharmaceuticals (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

Sarv Mitter Behl is associated with 0 companies as a director.

Sarv Mitter Behl has expertise in General Business.

Sarv Mitter Behl has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available